?Aris Global, a provider of software solutions for the life sciences industry, today announced the general release of agXchange IRT? (inbound receipt and triage) 6.0
Aris Global Expands Its Electronic Exchange Platform
with Release of agXchange IRT™ 6.0
Advanced software solution increases ability to report complete and accurate safety case information on time
AT THE DIA CONFERENCE (Boston, MA) - June 23, 2008: Aris Global, a leading provider of software solutions for the life sciences industry, today announced the general release of agXchange IRT™ (inbound receipt and triage) 6.0, a Web-based, solution for securely and efficiently receiving adverse event information, in different formats, from affiliates, co-development partners, consumers, healthcare providers, investigator sites, CROs, and other stakeholders.
During the DIA 44th Annual Meeting, Aris Global will be demonstrating and presenting agXchange IRT in its booth #834 in the Boston Convention and Exhibition Center.
agXchange IRT is the newest module of the agXchange™ gateway for extended electronic exchange, which also includes agXchange ESM™, an electronic submissions module that supports the import and export of adverse event data in E2B and extended E2B formats. agXchange IRT allows organizations to more closely integrate their affiliate offices into the processes of collecting and submitting safety information even if they do not have access to the central drug safety system. Comprehensive assessment and triage capabilities allow organizations to assess incoming potential safety items prior to case processing.
“Aris Global is committed to the extended electronic exchange gateway as the way organizations can take advantage of the inherent productivity benefits that automated paperless operations deliver,” said Wim Cypers, vice president, product management, Aris Global. “The agXchange IRT module will decrease the amount of time organizations spend collecting and verifying safety information, and will increase their ability to report complete and accurate safety information on time.”
About Aris Global
Aris Global (www.arisglobal.com) is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. More than 300 direct and indirect life science customers rely on the company’s advanced solutions for maintaining regulatory compliance, managing and mitigating risk, improving operational efficiency and easily sharing information on a global basis.
# # #
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.